Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 16,732 shares at $58.98 ($987K) on 2023-05-22, disclosed to the SEC on 2023-05-23.
Scheduled sale ($987k) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.96 | 6,403 | $378K | 38.3% |
| 2 | $58.96 | 6,403 | $378K | 38.3% |
| 3 | $58.98 | 1,913 | $113K | 11.4% |
| 4 | $58.98 | 1,913 | $113K | 11.4% |
| 5 | $59.66 | 100 | $6K | 0.6% |
| Total | $58.97 avg | 16,732 |
| $987K |
| 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |